Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Minolast-FXA Tablet SR

Prescription Icon
Prescription Required

Marketer

Leeford Healthcare Ltd

Salt Composition

Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg)

Overview Minolast-FXA Tablet SR

Asthmarelief-FXA SR is a dual-action medication employed in asthma prophylaxis. It alleviates allergic manifestations like nasal discharge, nasal congestion, sneezing, lacrimation, and respiratory congestion. Furthermore, it promotes bronchodilation, easing breathing by relaxing airway muscles. Asthmarelief-FXA SR is administered with or without food, following the physician's prescribed dosage and regimen. Dosage is individualized based on your condition and response. Continue treatment as directed; premature cessation may result in symptom recurrence and exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common adverse effects include nausea, emesis, abdominal pain, diarrhea, dermatitis, pruritus, dyspnea, and cephalalgia. Most are transient and self-limiting. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or mentally demanding tasks until effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Disclose any hepatic or renal impairments before commencing treatment to ensure appropriate dosage. Inform your doctor if pregnant, planning pregnancy, or breastfeeding.

Primary Ingredients of Minolast-FXA Tablet SR

No text provided to rephrase.

Uses of Minolast-FXA Tablet SR

Chronic obstructive pulmonary disease

Major Benefits of Minolast-FXA Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Minolast-FXA Tablet SR whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistency in timing is recommended.

Common Side effects of Minolast-FXA Tablet SR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Rash
  • Increased white blood cell count
  • Increased transaminase level in blood
  • Upper respiratory tract infection
  • Constipation
  • Abdominal discomfort
  • Abdominal distension
  • Heartburn
  • Loss of appetite
  • Esophageal bleeding
  • Nasal inflammation

How to use Minolast-FXA Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Minolast-FXA Tablet SR whole; avoid chewing, crushing, or breaking it. While you can consume it with or without food, consistent timing is recommended.

How Minolast-FXA Tablet SR works:

Minolast-FXA SR tablets contain a triple-action formula comprising montelukast, fexofenadine, and acebrophylline. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thus lessening airway and nasal inflammation and alleviating allergy symptoms. Fexofenadine, an antihistamine, provides relief from allergic manifestations such as nasal discharge, lacrimation, and sneezing. Acebrophylline, a mucolytic agent, facilitates expectoration by reducing mucus viscosity.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Minolast-FXA Tablet SR and alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Minolast-FXA Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Minolast-FXA Tablet SR use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Extended-release Minolast-FXA tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Minolast-FXA SR tablets. Dosage modification of Minolast-FXA SR tablets may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

Extended-release Minolast-FXA tablets are likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.

What if you forget to take Minolast-FXA Tablet SR :

Should you forget a Minolast-FXA Tablet SR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Minolast-FXA Tablet SR

LabelValue
Developing Habits No.
Treatment Category Breathing

FAQs on Minolast-FXA Tablet SR

Avoid taking Minolast-FXA Tablet SR with fruit juices (like apple, orange, or grapefruit) as this may reduce its effectiveness. Alcohol should also be avoided while using Minolast-FXA Tablet SR, as it intensifies the medication's drowsiness.
Continue taking Minolast-FXA Tablet SR as prescribed. Report any problems to your doctor immediately.
Minolast-FXA Tablet SR may cause dizziness, lightheadedness, weakness, or unsteadiness in some people. If this occurs, rest until symptoms subside before resuming activities.
Increasing your Minolast-FXA Tablet SR dosage beyond what's recommended won't improve its effectiveness; it may only worsen side effects. If your symptoms are worsening, consult your doctor.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Minolast-FXA Tablet SR
164
MRP 200
18% off